Two studies published recently in medical journals found devastating news for most the world.
Anti-malaria medication hydroxychloroquine failed to help hospitalized coronavirus patients.
The studies, both observational, looked at the outcomes of more than 2,000 patients.
The patients were hospitalized coronavirus victims in New York, reports Business Insider.
Hydroxychloroquine got attention early on in the pandemic as a potential treatment for COVID-19.
It has not been approved by the FDA for the treatment of COVID-19.